2/19/2023 0 Comments Amphetamine exampleMaternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Savitz DA, Chan RL, Herring AH, Howards PP, Hartmann KE. Caffeine intake during pregnancy and adverse birth outcomes: a systematic review and dose-response meta-analysis. Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. Hagg S, Spigset O, Mjorndal T, Dahlqvist R. Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR. Caffeine dependence syndrome: evidence from case histories and experimental evaluations. Strain EC, Mumford GK, Silverman K, Griffiths RR. A brief manualized treatment for problematic caffeine use: a randomized control trial. Critical review of dietary caffeine and blood pressure: a relationship that should be taken more seriously. Caffeine therapy for apnea of prematurity. Caffeine as an analgesic adjuvant for acute pain in adults. Current evidence for the use of coffee and caffeine to prevent age-related cognitive decline and alzheimer’s disease. Coffee, tea, caffeine and risk of depression: a systematic review and dose–response meta-analysis of observational studies. Grosso G, Micek A, Castellano S, Pajak A, Galvano F. Impact of coffee on liver diseases: a systematic review. Mitchell DC, Knight CA, Hockenberry J, Teplansky R, Hartman TJ. Effect of caffeine and testosterone on the proliferation of human hair follicles in vitro. 2006 83(supplement 1):S4–S7.įischer TW, Hipler UC, Elsner P. Abuse of prescription drugs and the risk of addiction. Severity of dependence: data from the DSM-IV field trials. Comparative epidemiology of dependence on tobacco, alcohol, controlled substances, and inhalants: basic findings from the National Comorbidity Survey. Arlington: American Psychiatric Association 2013.Īnthony JC, Warner LA, Kessler RD. Diagnostic and statistical manual of mental disorders. KeywordsĪmerican Psychiatric Association. The stimulants of particular focus in this chapter will be caffeine, cocaine, as well as amphetamine and amphetamine-type (AAT) stimulants. This chapter reviews the mechanisms of action of various stimulants, diagnostic features of different stimulant intoxication/withdrawal/use disorders, and evidence-based treatment modalities for these diagnostic entities. There are no pharmacotherapies that are FDA approved for the treatment of any stimulant use disorder, but several behavioral therapies, such as contingency management, have demonstrated promise. As a result of their non-medical and abuse potential, a robust illicit stimulant trade remains active worldwide. While some stimulants have relatively benign physiological profiles, such as caffeine, use of other stimulants such as amphetamines or cocaine can result in significant negative physiological and/or psychiatric consequences such as stroke or myocardial infarction, psychosis, and movement disorders, and also carry a high risk for physiological dependence and the development of use disorders (addiction). Certain stimulants are FDA approved for various medical and psychiatric conditions and are therefore available via prescription. The term stimulant refers to a diverse array of natural and synthetic compounds whose use results in varying degrees of euphoria, as well as heightened attention, wakefulness, and libido, in addition to sympathomimetic effects.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |